We are here to help   +49 2241 25515 0
  • Shopping Cart Shopping Cart
    0Shopping Cart
  • Products
    • Primary Cells & Culture Media
      • Primary Cells
      • Growth Media
      • Differentiation Media
      • Subculture & Reagents
    • Tissue Dissociation
      • Collagenase & Dispase
      • Papain & Trypsin
      • Elastase & Hyaluronidase
      • Tissue Dissociation Kits
    • Matrix Proteins / Bioprinting
      • Collagen
      • Extracellular Matrix Proteins
      • Tunable Stiffness
      • Adhesion Molecules & Peptides
    • iPSC Research
      • iPSC-Derived Cells
      • MEFs
      • Media & Reagents
      • Services & Products
      • iPSC Lines
    • Other Products
      • Enzymes
      • Natural Proteins
      • Staining Kits
      • Cultureware
    • Cell Signaling
      • Cytokines
      • Chemokines
      • Growth Factors
      • Neurotrophins
      • CD Antigens
    • Molecular Biology
      • DNase & Related Products
      • RNase & Related Products
      • Enzymes & Related Products
    • Antibodies
      • Coagulation
      • Immunology
      • Cell Biology
    • Haemostasis & Thrombosis
      • Coagulation Proteins
      • Factor Deficient Plasmas
      • Bone Related Proteins
      • Fluorogenic Substrates & Inhibitors
      • Sample Collection Tubes
  • Services
  • Brands
  • Company
  • Career
  • News
  • Contact
  • Downloads
    • Portfolio Flyer
  • Menu Menu
Home |Products|Haemostasis & Thrombosis|Fluorogenic Substrates & Inhibitors|Human Heparin Cofactor II

Human Heparin Cofactor II

Cat.-Nr.: HCII-0190

Description

Heparin cofactor II (HCII) (heparin cofactor A, antithrombin BM, dermatan sulfate cofactor, human leuserpin-2) is a single chain glycoprotein (Mr = 65,600, 10% carbohydrate) member of the serine protease inhibitor (serpin) family (1-3). Amino acid sequence analysis of heparin cofactor II reveals 3 potential N-glycosylation sites and 2 sulfated tyrosines located in two internal repeats of 7 residues located near the NH2-terminal (4-6). The plasma concentration is estimated to be 90 µg/ml (2). In the coagulation cascade, heparin cofactor II inhibits thrombin by formation of a bimolecular complex in the presence (k2 = 4.5×108 M-1min-1) and absence (k2 = 5.0×105 M-1min-1) of heparin (2, 7-9). This complex is stable to denaturants and essentially irreversible. In addition to heparin, a wide variety of polyanionic compounds accelerate inhibition of thrombin by HCII (3). Noteworthy among these compounds is dermatan sulfate, which accelerates inhibition of thrombin by HCII, but not antithrombin III (1,6,17) This feature has been utilized to develop a plasma based assay specific for heparin cofactor II (18). Although HCII shows only ~25% sequence homology to other serpins, the reactive site peptide (COOH-terminal 36 amino acids) released on inhibition of thrombin is 53% homologous to that released from antithrombin III (ATIII) by thrombin (4,9). The scissile bond in HCII is Leu-Ser which is unusual for an arginine specific protease inhibitor (4,9). In contrast to ATIII, the only coagulation protease inhibited by HCII is thrombin (20), Other proteases inhibited by HCII include -chymotrypsin, neutrophil cathepsin G and streptomyces griseus protease B (3,20). The major physiologic role of heparin cofactor II may remain to be discovered. Heparin cofactor II is prepared from fresh frozen plasma by a modification of the procedure of Griffith, et al., (9). Purity is assessed on SDS PAGE and activity is determined based on thrombin inhibition in the presence of dermatan sulfate. HCII is supplied in 50% (vol/vol) glycerol/H20 for storage at -20°C.

  • SUPPLIER:

    Haematologic TechnologiesProlytix

  • STATUS:

    In Stock

  • SIZE:

    100 µg

  • Overview

Overview

  • Species: Human
  • Keywords: Inhibitors
  • Specific Attributes: Protease Inhibitors
  • Product Type: Inhibitors
  • Formulation:50% glycerol/H2O/ 5 mM Calcium Chloride (vol/vol)
  • Purity:>95%
  • Localization:Plasma
  • Concentration of plasma:90 µg/ml
  • Mode of action:serine protease inhibitor; inhibits thrombin, a-chymotrypsin, neutrophil cathepsin G, streptomyces griseus protease B
  • Molecular Weight:65600
  • Extinction Coeff:5,93
  • Specific activity:700-1800 units/mg
  • Activity:Thrombin inhibition assay; One Unit will inhibit one NIH Unit of Thrombin
  • Isoelectric point:4.95-5.15
  • Structure:single chain glycoprotein, 3 potential N-glycosylation sites, two 7-amino acid residue repeats, reactive site sequence: TVTTVGFMPL-STQVRFTVDR
  • Percent carbohydrate:0.10%
  • Post translationnal modifications:3 sulfated tyrosines

RELATED PRODUCTS


  • Bovine Factor IXa-EGR

  • Horse anti-Human Factor V

  • Human alpha-Thrombin-DFP (active site blocked)

  • Human Factor Xa

  • Imprint
  • Privacy policy
Link to: Human Oral Keratinocytes (Gingiva) Link to: Human Oral Keratinocytes (Gingiva) Human Oral Keratinocytes (Gingiva) Link to: Human Glu-Plasminogen (affinity form II) Link to: Human Glu-Plasminogen (affinity form II) Human Glu-Plasminogen (affinity form II)
Scroll to top Scroll to top Scroll to top